Overexpression of p53 protein in squamous cell carcinomas of head and neck without apparent gene mutations

Diagnostic Molecular Pathology

Volumn 3, Issue 2, 1994, Pages 83-92

  Xu, Li ^a,c,e   Chen, Yao Tseng ^a,d,e   Huvos, Andrew G ^b,e   Zlotolow, Ian M ^c,e   Rettig, Wolfgang J ^a,e   Old, Lloyd J ^a,e   Garin Chesa, Pilar ^a,b,e  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^b Department of Pathology ^*  (United States)

^c Dental Service Department of Surgery ^*  (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Head and neck cancer; Immunohistochemistry; p53; PCR SSCP; Squamous cell carcinoma

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; PROTEIN P53;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA SEQUENCE; FRAMESHIFT MUTATION; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NONSENSE MUTATION; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; SQUAMOUS CELL CARCINOMA; TISSUE DISTRIBUTION;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; DNA PROBES; GENE EXPRESSION; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; MUTATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0028239526     PISSN: 10529551     EISSN: 15334066     Source Type: Journal    
DOI: 10.1097/00019606-199406000-00004     Document Type: Article

References (36)

1. Arai N, Nomura D, Yokota K, Wolf D, Brill E, Shohat O, Rotter V. Immunologically distinct p53 molecules generated by alternative splicing. Mol Cell Biol 1986; 6: 3232-9.
2. Baker SJ, Fearon ER, Nigro JM, et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989; 244: 217-21.
3. Banks L, Matlashewski G, Crawford L. Isolation of human- p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem 1986; 159:529-34.
4. Bartek J, Bartkova J, Vojtesek B, Staskova Z, Rejthar A, Kovarik J, Lane DP. Patterns of expression of the p53 tumor suppressor in human breast tissues and tumor in situ and in vitro. Int J Cancer 1990;46:839-44.
5. Bartek J, Iggo R, Gannon J, Lane DP. Genetic and immu nochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 1990; 5: 893-9.
6. Boring CC, Squires TS, Tong T. Cancer statistics, 1991. CA Cancer J Clin 1991; 41: 19-36.
7. Brachman DG, Graves D, Vokes E, et al. Occurrence of p53 gene deletions and human papillomavirus infection in human head and neck cancer. Cancer Res 1992; 52: 4832-6.
8. Buchman VL, Chumakov NN, Ninkina OP, Gerogiev GP. A variation in the structure of the protein-coding region of p53 gene. Gene 1988; 70: 245-52.
9. Cattoretti G, Rilke F, Andreola S, D’Amato L, Delia D. p53 expression in breast cancer. Int J Cancer 1988; 41: 178-83.
10. Davidoff AM, Humphrey PA, Iglehart JD, Marks JR. Genetic basis for p53 overexpression in human breast cancer. Proe Natl Acad Sei USA 1991; 88: 5006-10.
11. Dolcetti R, Doflioni C, Maestro R, et al. p53 overexpression is an early event in the development of human squamous cell carcinoma of the larynx: genetic and prognostic implications. Int J Canter 1992; 53: 178-82.
12. Feild JK, Spandidos DA, Malliri A, Yiagnisis GM, Stell PM. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer 1991; 64: 573-7.
13. Gannon JV, Greaves T, Iggo R, Lane DP. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 1990; 9: 1595-1602.
14. Garin-Chesa P, Fellinger EJ, Huvos AG, Beresford HR, Melamed MR, Triche TJ, Rettig WJ. lmmunohistochemical analysis of neural cell adhesion molecules. Am I Pathol 1991; 139: 275-86.
15. Gusterson BA, Anbazhagan R, Warren W, et al. Expression of p53 in premalignant and malignant squamous epithelium. Oncogene 1991; 6: 1785-9.
16. Harlow ED, Crawford LV, Pirn DC, Willamson NM. Monoclonal antibodies specific for simian virus 40 tumor antigens. I Virol 1981; 39: 861-9.
17. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49-53.
18. Iggo R, Gatter K, Bartek J, Lane D, Harris AL. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990; 335: 675-9.
19. Lamb P, Crawford L. Characterization of the human p53 gene. Mol Cell Biol 1986; 6: 1379-85.
20. Lane DP, Benchimol S. p53: oncogene or antioncogene'? Gene Dev 1990; 4: 1-8.
21. Levine AJ, Momand J, Finlay CA. The p53 tumor suppressor gene. Nature 1991; 351: 453-6.
22. Maestro R, Dolectti R, Gasparotto D, et al. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene 1992; 7: 1159-66.
23. Moll UM, Riou G, Levine AJ. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci USA 1992; 89: 7262-6.
24. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989; 86: 2766-70.
25. Parkin DM, Laara E, Muire CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988; 41: 184-97.
26. Rodrigues NR, Rowan A, Smith MEF Kerr IB, Bodmer WF, Gannon JV, Lane DP. p53 mutations in colorectal cancer. Proe Natl Acad Sci USA 1990; 87: 7555-9.
27. Shirasawa S, Urabe K, Yanagawa Y, Toshitani K, Iwama T. Sukumar S. Mutations in p53 as potential molecular markers for human breast cancer. Proc Natl Acad Sci USA 1991; 88: 10657-61.
28. Somers KD, Merrick MA, Lopez ME, Incognito LS, Schechter GL, Casey G. Frequent p53 mutations in head and neck cancer. Cancer Res 1992; 52: 5995-6000.
29. Takahashi T, Nau MM, Chiba I, et al. p53 a frequent target for genetic abnormalities in lung cancer. Science 1989, 246: 491-4.
30. Tan T-H, Wallis J, Levine AJ. Identification of the p53 protein domain involved in formation of the simian virus 40 large T-antigen-p53 protein complex. J Virol 1986; 59: 574-83.
31. Thompson AM, Anderson TJ, Condie A, et al. p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters. Ini J Cancer 1992; 50: 528-32.
32. Ullrich SJ, Anderson CW, Mercer WE, Appella E. The p53 tumor suppressor protein, a modulator of cell proliferation. J Biol Chem 1992; 267: 15259-62.
33. Wade-Evans A, Jenkins JR. Precise epitope mapping of the murine transformations-associated protein, p53. EMBO J 1985; 4: 699-706.
34. Wagata T, Shibagaki I, Imamura M, et al Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas. Cancer Res 1993; 53: 846-50.
35. Walker RA, Dearing SJ, Lane DP, Varley JM. Expression of p53 protein in infiltrating and in-situ breast carcinomas. J Pathol 1991; 165: 203-11.
36. Zarbo RJ, Crissman JD. The surgical pathology of head and neck cancer. Semin Oncol 1988; 15: 10-19.